Ubs Asset Management Americas Inc Heron Therapeutics, Inc. Transaction History

Ubs Asset Management Americas Inc

$381 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$4.63 - $9.94 $1,185 - $2,544	-256 Reduced 0.23%	110,752 $633,000
Q4 2021 Feb 14, 2022	BUY	$8.35 - $12.6 $109,126 - $164,669	13,069 Added 13.34%	111,008 $1.01 Million
Q3 2021 Nov 15, 2021	SELL	$10.13 - $15.0 $55,117 - $81,615	-5,441 Reduced 5.26%	97,939 $1.05 Million
Q2 2021 Aug 16, 2021	BUY	$13.27 - $18.48 $63,841 - $88,907	4,811 Added 4.88%	103,380 $1.6 Million
Q1 2021 May 14, 2021	BUY	$14.49 - $20.72 $60,437 - $86,423	4,171 Added 4.42%	98,569 $1.6 Million
Q3 2020 Nov 13, 2020	BUY	$13.67 - $17.77 $58,425 - $75,948	4,274 Added 4.74%	94,398 $1.4 Million
Q2 2020 Aug 14, 2020	SELL	$10.89 - $21.47 $9,997 - $19,709	-918 Reduced 1.01%	90,124 $1.33 Million
Q1 2020 May 15, 2020	SELL	$10.23 - $24.56 $951 - $2,284	-93 Reduced 0.1%	91,042 $1.07 Million
Q4 2019 Feb 14, 2020	BUY	$17.42 - $26.61 $34,630 - $52,900	1,988 Added 2.23%	91,135 $2.14 Million
Q3 2019 Nov 14, 2019	BUY	$16.36 - $21.39 $380,991 - $498,130	23,288 Added 35.36%	89,147 $1.65 Million
Q2 2019 Aug 15, 2019	BUY	$16.93 - $26.22 $140,180 - $217,101	8,280 Added 14.38%	65,859 $0
Q1 2019 May 14, 2019	BUY	$23.15 - $28.34 $221,105 - $270,675	9,551 Added 19.89%	57,579 $0
Q4 2018 Feb 13, 2019	BUY	$22.03 - $32.01 $181,703 - $264,018	8,248 Added 20.73%	48,028 $1.25 Million
Q3 2018 Nov 14, 2018	BUY	$30.0 - $40.85 $171,300 - $233,253	5,710 Added 16.76%	39,780 $0
Q2 2018 Aug 14, 2018	BUY	$26.4 - $42.0 $210,328 - $334,614	7,967 Added 30.52%	34,070 $0
Q1 2018 May 14, 2018	BUY	$18.43 - $28.8 $247,017 - $386,006	13,403 Added 105.54%	26,103 $0
Q4 2017 Feb 09, 2018	BUY	$14.8 - $18.85 $187,960 - $239,395	12,700	12,700 $0

Others Institutions Holding HRTX

# of Institutions

179

Shares Held

121M

Call Options Held

80.4K

Put Options Held

94.9K

Rubric Capital Management LP New York, NY

26.7M
Shares

$41.4 Million
1.48% of portfolio
Adage Capital Partners Gp, L.L.C. Boston, MA

8.85M
Shares

$13.7 Million
0.03% of portfolio
Vanguard Group Inc Valley Forge, PA

8.72M
Shares

$13.5 Million
0.0% of portfolio
Black Rock Inc. New York, NY

8.33M
Shares

$12.9 Million
0.0% of portfolio
Velan Capital Investment Management LP Alpharetta, GA

6.99M
Shares

$10.8 Million
28.8% of portfolio

View Full List

About HERON THERAPEUTICS, INC.

Ticker HRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,774,000
Market Cap $184M
Description
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...

More about HRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Asset Management Americas Inc with notifications on news.

Account